629 related articles for article (PubMed ID: 36056434)
21. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
[TBL] [Abstract][Full Text] [Related]
22. Longitudinal Copy-Number Alteration Analysis in Plasma Cell-Free DNA of Neuroendocrine Neoplasms is a Novel Specific Biomarker for Diagnosis, Prognosis, and Follow-up.
Boons G; Vandamme T; Mariën L; Lybaert W; Roeyen G; Rondou T; Papadimitriou K; Janssens K; Op de Beeck B; Simoens M; Demey W; Dero I; Van Camp G; Peeters M; Op de Beeck K
Clin Cancer Res; 2022 Jan; 28(2):338-349. PubMed ID: 34759042
[TBL] [Abstract][Full Text] [Related]
23. Noninvasive Detection of Bladder Cancer by Shallow-Depth Genome-Wide Bisulfite Sequencing of Urinary Cell-Free DNA for Methylation and Copy Number Profiling.
Cheng THT; Jiang P; Teoh JYC; Heung MMS; Tam JCW; Sun X; Lee WS; Ni M; Chan RCK; Ng CF; Chan KCA; Chiu RWK; Lo YMD
Clin Chem; 2019 Jul; 65(7):927-936. PubMed ID: 30988170
[TBL] [Abstract][Full Text] [Related]
24. Fragmentomic analysis of circulating tumor DNA-targeted cancer panels.
Helzer KT; Sharifi MN; Sperger JM; Shi Y; Annala M; Bootsma ML; Reese SR; Taylor A; Kaufmann KR; Krause HK; Schehr JL; Sethakorn N; Kosoff D; Kyriakopoulos C; Burkard ME; Rydzewski NR; Yu M; Harari PM; Bassetti M; Blitzer G; Floberg J; Sjöström M; Quigley DA; Dehm SM; Armstrong AJ; Beltran H; McKay RR; Feng FY; O'Regan R; Wisinski KB; Emamekhoo H; Wyatt AW; Lang JM; Zhao SG
Ann Oncol; 2023 Sep; 34(9):813-825. PubMed ID: 37330052
[TBL] [Abstract][Full Text] [Related]
25. Circulating-tumour DNA methylation of HAND1 gene: a promising biomarker in early detection of colorectal cancer.
Shavali M; Moradi A; Tahmaseb M; Mohammadian K; Ganji SM
BMC Med Genomics; 2024 Apr; 17(1):117. PubMed ID: 38689296
[TBL] [Abstract][Full Text] [Related]
26. Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer.
Wyatt AW; Annala M; Aggarwal R; Beja K; Feng F; Youngren J; Foye A; Lloyd P; Nykter M; Beer TM; Alumkal JJ; Thomas GV; Reiter RE; Rettig MB; Evans CP; Gao AC; Chi KN; Small EJ; Gleave ME
J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 29206995
[TBL] [Abstract][Full Text] [Related]
27. Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case-control study.
Sui J; Wu X; Wang C; Wang G; Li C; Zhao J; Zhang Y; Xiang J; Xu Y; Nian W; Cao F; Yu G; Lou Z; Hao L; Liu L; Li B; Zhang Z; Cai S; Liu H; Lan P; Zhang W
Clin Epigenetics; 2021 Feb; 13(1):26. PubMed ID: 33536049
[TBL] [Abstract][Full Text] [Related]
28. A novel xenonucleic acid-mediated molecular clamping technology for early colorectal cancer screening.
Sun Q; Pastor L; Du J; Powell MJ; Zhang A; Bodmer W; Wu J; Zheng S; Sha MY
PLoS One; 2021; 16(10):e0244332. PubMed ID: 34610014
[TBL] [Abstract][Full Text] [Related]
29. Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer.
Luo H; Zhao Q; Wei W; Zheng L; Yi S; Li G; Wang W; Sheng H; Pu H; Mo H; Zuo Z; Liu Z; Li C; Xie C; Zeng Z; Li W; Hao X; Liu Y; Cao S; Liu W; Gibson S; Zhang K; Xu G; Xu RH
Sci Transl Med; 2020 Jan; 12(524):. PubMed ID: 31894106
[TBL] [Abstract][Full Text] [Related]
30. ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA.
Huebner A; Black JRM; Sarno F; Pazo R; Juez I; Medina L; Garcia-Carbonero R; Guillén C; Feliú J; Alonso C; Arenillas C; Moreno-Cárdenas AB; Verdaguer H; Macarulla T; Hidalgo M; McGranahan N; Toledo RA
Genome Med; 2023 Apr; 15(1):27. PubMed ID: 37081523
[TBL] [Abstract][Full Text] [Related]
31. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
[TBL] [Abstract][Full Text] [Related]
32. Multi-dimensional cell-free DNA-based liquid biopsy for sensitive early detection of gastric cancer.
Yu P; Chen P; Wu M; Ding G; Bao H; Du Y; Xu Z; Yang L; Fang J; Huang X; Lai Q; Wei J; Yan J; Yang S; He P; Wu X; Shao Y; Su D; Cheng X
Genome Med; 2024 Jun; 16(1):79. PubMed ID: 38849905
[TBL] [Abstract][Full Text] [Related]
33. Cell-free DNA copy number variations in plasma from colorectal cancer patients.
Li J; Dittmar RL; Xia S; Zhang H; Du M; Huang CC; Druliner BR; Boardman L; Wang L
Mol Oncol; 2017 Aug; 11(8):1099-1111. PubMed ID: 28504856
[TBL] [Abstract][Full Text] [Related]
34. Detection of Circulating Tumor DNA in Plasma Using Targeted Sequencing.
Sun X; Liu X; Zhao Y; Tian G; Wang W
Methods Mol Biol; 2023; 2695():27-46. PubMed ID: 37450110
[TBL] [Abstract][Full Text] [Related]
35. Metastatic Colorectal Cancer Treatment Response Evaluation by Ultra-Deep Sequencing of Cell-Free DNA and Matched White Blood Cells.
van 't Erve I; Medina JE; Leal A; Papp E; Phallen J; Adleff V; Chiao EJ; Arun AS; Bolhuis K; Simmons JK; Karandikar A; Valkenburg KC; Sausen M; Angiuoli SV; Scharpf RB; Punt CJA; Meijer GA; Velculescu VE; Fijneman RJA
Clin Cancer Res; 2023 Mar; 29(5):899-909. PubMed ID: 36534496
[TBL] [Abstract][Full Text] [Related]
36. Multimodal analysis of cell-free DNA whole-methylome sequencing for cancer detection and localization.
Bie F; Wang Z; Li Y; Guo W; Hong Y; Han T; Lv F; Yang S; Li S; Li X; Nie P; Xu S; Zang R; Zhang M; Song P; Feng F; Duan J; Bai G; Li Y; Huai Q; Zhou B; Huang YS; Chen W; Tan F; Gao S
Nat Commun; 2023 Sep; 14(1):6042. PubMed ID: 37758728
[TBL] [Abstract][Full Text] [Related]
37. Plasma or Serum: Which Is Preferable for Mutation Detection in Liquid Biopsy?
Pittella-Silva F; Chin YM; Chan HT; Nagayama S; Miyauchi E; Low SK; Nakamura Y
Clin Chem; 2020 Jul; 66(7):946-957. PubMed ID: 32516802
[TBL] [Abstract][Full Text] [Related]
38. Multi-dimensional fragmentomic assay for ultrasensitive early detection of colorectal advanced adenoma and adenocarcinoma.
Ma X; Chen Y; Tang W; Bao H; Mo S; Liu R; Wu S; Bao H; Li Y; Zhang L; Wu X; Cai S; Shao Y; Liu F; Peng J
J Hematol Oncol; 2021 Oct; 14(1):175. PubMed ID: 34702327
[TBL] [Abstract][Full Text] [Related]
39. A feasibility study of colorectal cancer diagnosis via circulating tumor DNA derived CNV detection.
Molparia B; Oliveira G; Wagner JL; Spencer EG; Torkamani A
PLoS One; 2018; 13(5):e0196826. PubMed ID: 29791457
[TBL] [Abstract][Full Text] [Related]
40. A novel cell-free DNA methylation-based model improves the early detection of colorectal cancer.
Wu X; Zhang Y; Hu T; He X; Zou Y; Deng Q; Ke J; Lian L; He X; Zhao D; Cai X; Chen Z; Wu X; Fan JB; Gao F; Lan P
Mol Oncol; 2021 Oct; 15(10):2702-2714. PubMed ID: 33694305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
